[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HRP20030993A2 - Inhalation capsules - Google Patents

Inhalation capsules

Info

Publication number
HRP20030993A2
HRP20030993A2 HR20030993A HRP20030993A HRP20030993A2 HR P20030993 A2 HRP20030993 A2 HR P20030993A2 HR 20030993 A HR20030993 A HR 20030993A HR P20030993 A HRP20030993 A HR P20030993A HR P20030993 A2 HRP20030993 A2 HR P20030993A2
Authority
HR
Croatia
Prior art keywords
inhalation capsules
inhalation
capsules
Prior art date
Application number
HR20030993A
Inventor
Bechtold-Peters Karoline
Hochrainer Dieter
Trunk Michael
Walz Michael
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7687020&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20030993(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg. filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg.
Publication of HRP20030993A2 publication Critical patent/HRP20030993A2/en
Publication of HRP20030993B1 publication Critical patent/HRP20030993B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/451Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001Particle size control
    • A61M11/003Particle size control by passing the aerosol trough sieves or filters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033Details of the piercing or cutting means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20030993A 2001-06-01 2003-11-28 Inhalation capsules HRP20030993B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10126924A DE10126924A1 (en) 2001-06-01 2001-06-01 Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability
PCT/EP2002/005600 WO2002098874A2 (en) 2001-06-01 2002-05-27 Inhalation capsules

Publications (2)

Publication Number Publication Date
HRP20030993A2 true HRP20030993A2 (en) 2005-08-31
HRP20030993B1 HRP20030993B1 (en) 2011-10-31

Family

ID=7687020

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030993A HRP20030993B1 (en) 2001-06-01 2003-11-28 Inhalation capsules

Country Status (37)

Country Link
EP (2) EP1379220B1 (en)
JP (3) JP4447311B2 (en)
KR (2) KR100921904B1 (en)
CN (3) CN101697965A (en)
AR (2) AR034346A1 (en)
AT (1) ATE285752T1 (en)
AU (2) AU2002344354B2 (en)
BG (1) BG65655B1 (en)
BR (1) BR0209366A (en)
CA (1) CA2448425C (en)
CH (1) CH1379220H1 (en)
CO (1) CO5540379A2 (en)
CZ (1) CZ300284B6 (en)
DE (2) DE10126924A1 (en)
EA (1) EA005188B1 (en)
EC (2) ECSP034868A (en)
EE (1) EE05416B1 (en)
EG (1) EG24227A (en)
ES (1) ES2236590B5 (en)
HR (1) HRP20030993B1 (en)
HU (3) HU230058B1 (en)
IL (2) IL158917A0 (en)
ME (1) ME00301B (en)
MX (1) MXPA03010990A (en)
MY (1) MY126253A (en)
NO (1) NO332857B3 (en)
NZ (1) NZ530356A (en)
PE (1) PE20030071A1 (en)
PL (2) PL203801B1 (en)
PT (1) PT1379220E (en)
RS (1) RS50353B (en)
SI (1) SI1379220T1 (en)
SK (2) SK287379B6 (en)
TW (1) TWI327921B (en)
UA (1) UA75659C2 (en)
WO (1) WO2002098874A2 (en)
ZA (1) ZA200308340B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME00245B (en) 2000-10-12 2011-02-10 Boehringer Ingelheim Int Novel tiotropium-containing inhalation powder
DE10126924A1 (en) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability
DE10212264A1 (en) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Crystalline micronisate, process for its preparation and its use for the manufacture of a medicament
JP2005530765A (en) * 2002-05-07 2005-10-13 ネクター セラピューティクス Capsules for dry powder inhalers and methods of making and using the same
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10255387A1 (en) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg New tiotropium-containing powder formulation for inhalation
DE10258360A1 (en) * 2002-12-12 2004-06-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Chamber for accommodation of disposable capsules for powder inhalers has an inner surface with protruding elements serving as distance pieces between the capsules
DE10352277A1 (en) * 2003-11-08 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg powder inhaler
SE0303570L (en) 2003-12-03 2005-06-04 Microdrug Ag Moisture-sensitive medical product
SE0303269L (en) * 2003-12-03 2005-06-04 Microdrug Ag Medical product
GB0503738D0 (en) 2005-02-23 2005-03-30 Optinose As Powder delivery devices
US7694676B2 (en) 2005-04-22 2010-04-13 Boehringer Ingelheim Gmbh Dry powder inhaler
JP4825455B2 (en) * 2005-05-02 2011-11-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Powder inhaler
DE102006016901A1 (en) * 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Mouthpiece for an inhaler
DE102006016904A1 (en) 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg inhaler
GB0716026D0 (en) 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
DE102007036411A1 (en) 2007-07-20 2009-02-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg powder inhaler
DE102007052871A1 (en) * 2007-11-02 2009-05-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Capsule for receiving pharmaceutical drug formulations
CA2714178A1 (en) * 2008-02-08 2009-08-13 Boehringer Ingelheim International Gmbh Method and device for filling capsules
EP2172190A1 (en) * 2008-10-02 2010-04-07 Laboratorios Liconsa, S.A. Inhalable particles comprising tiotropium
PT3578169T (en) 2009-02-26 2024-07-29 Glaxo Group Ltd Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
WO2010110760A1 (en) * 2009-03-27 2010-09-30 Mahmut Bilgic Compositions comprising water with deuterium for the prevention or treatment of allergic diseases and a process for the preparation thereof
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
WO2011152804A2 (en) 2010-06-03 2011-12-08 Mahmut Bilgic Process for dry powder formulations
DE202011102694U1 (en) 2011-06-29 2011-12-19 Zisser Gmbh Inhaler for home users
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
EA036153B1 (en) 2012-07-05 2020-10-06 Арвен Айлак Санайи Ве Тиджарет А.С. Pharmaceutical composition for inhalation, packed dosage form, capsule, method of treating obstructive airway diseases and pharmaceutical kit
DE202013000774U1 (en) 2013-01-21 2013-04-15 Rhinofilt GmbH Miniaturized inhalation device for home use
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
CN108295042A (en) * 2018-03-05 2018-07-20 上海祺宇生物科技有限公司 A kind of plant hollow capsule and its capsule for sucking medicament
CN108451920A (en) * 2018-03-14 2018-08-28 绍兴康可胶囊有限公司 A kind of suction mist formula capsule and preparation method thereof
CN114848605B (en) * 2022-03-25 2023-08-11 上海方予健康医药科技有限公司 Gelatin capsule for inhalation of powder fog agent

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (en) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them
WO1993025193A1 (en) * 1992-06-12 1993-12-23 Teijin Limited Pharmaceutical preparation for intra-airway administration
US6228394B1 (en) * 1997-10-14 2001-05-08 Boehringer Ingelheim Pharmaceuticals, Inc. Supercritical fluid extraction of mould lubricant from hard shell capsules
DE19835346A1 (en) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Two-part capsule for pharmaceutical preparations for powder inhalers
JP2000143502A (en) * 1998-11-11 2000-05-23 Shionogi Qualicaps Kk Inhalant preparation
EP2266548B1 (en) * 1998-11-13 2020-05-20 Jagotec AG Dry powder for inhalation
DE19921693A1 (en) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects
EP1072258A1 (en) * 1999-07-28 2001-01-31 Greither, Peter Capsule for the release of bacteria, containing lyophilised bacteria and a method for the production thereof
CA2387212A1 (en) * 1999-10-12 2001-04-19 Kaken Pharmaceutical Co., Ltd. Dry powder inhalation and a method for the preparation thereof
DE10126924A1 (en) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability

Also Published As

Publication number Publication date
EP1379220B1 (en) 2004-12-29
NO332857B1 (en) 2013-01-21
BG108380A (en) 2004-11-30
CN1512875A (en) 2004-07-14
WO2002098874A2 (en) 2002-12-12
MXPA03010990A (en) 2004-02-27
ZA200308340B (en) 2004-05-21
PL203801B1 (en) 2009-11-30
NO332857B3 (en) 2016-01-25
PL387118A1 (en) 2004-12-13
KR20090010140A (en) 2009-01-28
PL364108A1 (en) 2004-12-13
NO20035265D0 (en) 2003-11-27
EG24227A (en) 2008-11-10
AU2008203057C8 (en) 2017-04-06
YU93503A (en) 2006-05-25
AR084804A2 (en) 2013-06-26
ECSP034868A (en) 2004-03-23
HU230058B1 (en) 2015-06-29
RS50353B (en) 2009-11-10
MY126253A (en) 2006-09-29
KR100952321B1 (en) 2010-04-09
SK16202003A3 (en) 2004-05-04
CN101697965A (en) 2010-04-28
AU2008203057C1 (en) 2017-05-18
JP2006143747A (en) 2006-06-08
AU2002344354B2 (en) 2008-08-07
CA2448425C (en) 2010-12-21
ATE285752T1 (en) 2005-01-15
BR0209366A (en) 2004-06-08
SK287346B6 (en) 2010-07-07
PT1379220E (en) 2005-03-31
IL158917A0 (en) 2004-05-12
EP1379220A2 (en) 2004-01-14
EP1508330A1 (en) 2005-02-23
EE05416B1 (en) 2011-06-15
NO20035265L (en) 2003-11-27
SK287379B6 (en) 2010-08-09
HU231082B1 (en) 2020-06-29
JP4447311B2 (en) 2010-04-07
PE20030071A1 (en) 2003-03-04
KR20040007638A (en) 2004-01-24
CN101829072A (en) 2010-09-15
SI1379220T1 (en) 2005-04-30
NZ530356A (en) 2005-05-27
ES2236590T3 (en) 2005-07-16
ECSP11004868A (en) 2011-02-28
AR034346A1 (en) 2004-02-18
HU230827B1 (en) 2018-07-30
UA75659C2 (en) 2006-05-15
HUP0400666A3 (en) 2009-06-29
JP2008050364A (en) 2008-03-06
JP2005500279A (en) 2005-01-06
PL205714B1 (en) 2010-05-31
HRP20030993B1 (en) 2011-10-31
ME00301B (en) 2011-05-10
EA200301275A1 (en) 2004-06-24
EE200300595A (en) 2004-02-16
MEP42508A (en) 2011-02-10
CA2448425A1 (en) 2002-12-12
KR100921904B1 (en) 2009-10-16
WO2002098874A3 (en) 2003-09-12
JP4787034B2 (en) 2011-10-05
EA005188B1 (en) 2004-12-30
AU2008203057A1 (en) 2008-07-31
BG65655B1 (en) 2009-05-29
IL158917A (en) 2008-11-03
DE50201898D1 (en) 2005-02-03
HUP1500188A2 (en) 2005-03-29
HUP0400666A2 (en) 2005-03-29
CO5540379A2 (en) 2005-07-29
AU2008203057B2 (en) 2011-12-08
CZ300284B6 (en) 2009-04-08
DE10126924A1 (en) 2002-12-05
CZ20033579A3 (en) 2004-05-12
CH1379220H1 (en) 2018-10-31
TWI327921B (en) 2010-08-01
ES2236590B5 (en) 2018-03-05

Similar Documents

Publication Publication Date Title
HRP20030993A2 (en) Inhalation capsules
IL157374A0 (en) Capsule
AU2002344354A1 (en) Inhalation capsules
GB0112834D0 (en) Medicaments
AU2002365120A8 (en) Medicaments
EP1417988A4 (en) Respirator
IL157580A0 (en) Inhalation drug combination
GB0128415D0 (en) Medicaments
GB0102902D0 (en) Medicaments
GB0115761D0 (en) Capsules
GB0101239D0 (en) Medicinal aerosols
GB0105469D0 (en) Medicaments
GB0115182D0 (en) Medicaments
CA93371S (en) Inhaler
CA93370S (en) Inhaler
GB0112144D0 (en) Capsules
GB0110221D0 (en) Inhaler
GB0110229D0 (en) Inhaler
AU149744S (en) Inhaler
GB0130794D0 (en) Inhaler
GB0109081D0 (en) Inhaler
GB0109215D0 (en) Medicaments
GB0115988D0 (en) Medicaments
GB0101502D0 (en) Medicaments
GB0101414D0 (en) Medicaments

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
PPPN Proposal for the declaration of nullity of a patent
PPND Declaration of nullification in part
ZALP Appeal filed
ODRP Renewal fee for the maintenance of a patent

Payment date: 20190506

Year of fee payment: 18

ODRP Renewal fee for the maintenance of a patent

Payment date: 20200520

Year of fee payment: 19

ZALO Appeal rejected/withdrawn /refused
ODRP Renewal fee for the maintenance of a patent

Payment date: 20210517

Year of fee payment: 20

USP1 Administrative dispute
PB20 Patent expired after termination of 20 years

Effective date: 20220527

USP2 Decision of an administrative court